Genetic heterogeneity of benign thyroid lesions

Analytical Cellular Pathology

Volumn 16, Issue 2, 1998, Pages 101-110

  Ferrer Roca, O ^a   Perez Gomez J A ^a   Cigudosa, J C ^a   Gomez E ^a   Estevez M ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Benign tumours; Chromosome 1; Chromosome 17; Clonal detection; In situ hybridization; Karyotyping; t(5,19); Thyroid; Trisomies

Indexed keywords

ANEUPLOIDY; ARTICLE; CHROMOSOME TRANSLOCATION 19; CHROMOSOME TRANSLOCATION 5; CYTOGENETICS; FLOW CYTOMETRY; GENETIC HETEROGENEITY; GOITER; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THYROID ADENOMA; THYROID DISEASE; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA;

EID: 0031960428     PISSN: 09218912     EISSN: None     Source Type: Journal    
DOI: 10.1155/1998/275452     Document Type: Article

References (35)

1. A.A. Al-Saadi and W.H. Beierwaltes, Chromosomal changes in rat in thyroid cells during iodine depletion and repletion, Cancer Res. 26 (1966), 676-688.
2. A.A. Axelrad and C.P. Leblond, Induction of thyroid tumours in rats by low iodine diet, Cancer 8 (1955), 339-367.
3. G. Belge, B. Thode, V. Rippe, S. Bartnizke and J. Bullerdiek, A characteristic sequence of trisomies starting with trisomy 7 in benign thyroid tumours, Hum. Genet. 94 (1994), 198-202.
4. G. Belge, B. Thode, S. Bartnizke and J. Bullerdiek, Cytogenetic biclonality corresponding to multiphasic differentiation in an atypical adenoma, Cancer Genet. Cytogenet. 78 (1994), 102-104.
5. L. Bondenson, A. Bondenson, O. Lindholm and S. Tibblin, Morphometric studies on nuclei in smears of fine needle aspirates from oxyphilic tumours of the thyroid, Acta Cytol. 27 (1983), 437-440.
6. T. Bottger, D. Potratz, B. Schermus, J. Klupp, M. Stockle and T. Junginger, The value of quantitative DNA analysis in evaluating the prognosis of differentiated thyroid cancer, Chirurg. 65 (1994), 190-193.
7. J.C. Cigudosa, A. Pedrosa Guerra, A. Otero Gómez, J.L. Carrasco Juan, J.A. Pérez Gómez, O. Ferrer-Roca and J.L. García Miranda, Translocation (5,19)(q13,q13) in a multinodular thyroid goitre, Cancer Genet. Cytogenet. 82 (1995), 67-69.
8. P. Elfving, J.C. Cigudosa, R. Lundgrem, U. Kristoffersson, N. Mandhal, S. Heim and F. Mitelman, Trisomy 7, trisomy 10, and loss of the Y chromosome in short-term cultures of normal kidney tissue, Cytogenet. Cell Genet. 53 (1990), 123-125.
9. P. Elfving, R. Lundgrem, J.C. Cigudosa, N. Mandhal, S. Heim and F. Mitelman, Trisomy 7 in non-neoplastic Kidney tissue cultured with and without EGF, Cancer Genet. Cytogenet. 64 (1992), 99-100.
10. S.B. Ewers, E. Langstrom, B. Baldetorp and D. Killander, Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations, Cytometry 5 (1984), 408-419.
11. G.E. Feichter and K. Goerttle, Age-related nuclear size variability of thyreocytes in thyroid aspirates, Anal. Quant. Cytol. 5 (1983), 75-78.
12. O. Ferrer-Roca and J. Egozcue, Estudio Etiopatogénico del cáncer y su importancia clinica V. Correlacion somaticoviral y teoria de la correlacion cariotipo-tumoural, Med. Clin. 65 (1975), 428-433.
13. O. Ferrer-Roca, Clonal evolution of goiters, in: Tissue Culture in the Study of Tumors, Pacini, ed., Pisa, 1981, pp. 145-151.
14. O. Ferrer-Roca, E. Ballester-Guardia and J.A. Martin-Rodriguez, Morphometric, densitometric and flow cytometric criteria for the automated classification of thyroid lesions, Anal. Quant. Cytol. Histol. 22 (1990), 48-55.
15. P.J. Fialkow, Autoimmunity and chromosomal aberrations, Am. J. Hum. Genet. 18 (1966), 93-108.
16. P.J. Fialkow, The origin and development of human tumours studied with cell markers, New Engl. J. Med. 291 (1974), 26-35.
17. G.W. Gill, J.K. Frost and K.A. Miller, A new formula for a half oxidased hematoxylin solution that neither overstains or requires differentiation, Acta Cytol. 18 (1974), 300-311.
18. M.R. Hapke and L.P. Dehner, The optically clear nucleus. A reliable sign of papillary carcinoma of the thyroid?, Am. J. Surg. Pathol. 3 (1979), 31-38.
19. D.W. Hedley, M.L. Friedlander, I.W. Taylor, C.A. Rugg and E.A. Musgrove, Methods for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry, J. Histochem. Cytochem. 31 (1983), 1333-1335.
20. J. Jenderny, E. Koster, A. Meyer, O. Borchers, W. Grote, D. Harms and U. Janing, Detection of chromosome aberrations in paraffin sections of seven gonadal yolk sac tumours of childhood, Hum. Genet. 96 (1995), 644-650.
21. H. Joensuu and P.J. Klemi, DNA aneuploidy in adenomas of endocrine organs, Am. J. Pathol. 132 (1988), 145-151.
22. J.G. Jonasson and J. Hrafnkelsson, Nuclear DNA analysis and prognosis in carcinoma of the thyroid gland. A nation wide study in Iceland on carcinomas diagnosed 1995-1990, Virchows Arch. 425 (1994), 349-355.
23. P. Kopp, E.T. Kimura, S. Aeschiman, M. Oestreicher, A. Tobler, M.F. Fey and H. Studer, Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters, J. Clin. Endocrin. Metab. 79 (1994), 134-139.
24. G.L. Lukacs, G. Balazs, I. Zs-Nagy and M. Tivadar, Clinical meaning of DNA content in the long term behaviour of follicular thyroid tumours: a 12 years follow up, Eur. J. Surg. 160 (1994), 417-423.
25. T. Oyhama, T. Ishida, K. Ishii, S. Sakurai, T. Joshita, A. Sakamoto and T. Nakajima, Encapsulated papillary carcinoma of the thyroid gland clinicopathological and cytofluorometric study in comparison with non-encapsulated papillary carcinoma, Acta Pathol. Jpn. 43 (1993), 516-521.
26. T. Oyhama, A.L. Vickery, F.I. Preffer and R.B. Colvin, A comparative study of flow cytometry and histopathological findings in thyroid follicular carcinomas and adenomas, Hum. Pathol. 25 (1994), 271-275.
27. I. Salmon, P. Gasperin, M. Remmelink, I. Rahier, P. Rocmans, J.L. Pastels, R. Heimann and R. Kiss, Ploidy level and proliferative activity measurements in a series of 407 thyroid tumours or other pathologic conditions, Hum. Pathol. 24 (1993), 912-920.
28. S.E. Shackney, C.A. Smith, B.W. Miller, D.R. Burholt, K. Murthat, H.R. Giles, D.M. Ketteres and A.A. Pollice, Model for the genetic evolution of human solid tumours, Cancer Res. 49 (1989), 3344-3354.
29. C.R. Schad and G.W. Dewald, Building a new clinical test for fluorescence in situ hybridization, Appl. Cytogenet. 21 (1995), 1-41.
30. V. Smejkal, E. Smejkolova, M. Rosa, V. Zeman and K. Smetana, Cytologic changes simulating malignancy in Thyrotoxic Goiters treated with Carbimazole, Acta Cytol. 29 (1985), 173-178.
31. P. Smerdely, V. Pitsiaves and S.C. Boyages, Evidence that inhibitory effects of iodide on thyroid cell proliferation are due to arrest of cell cycle at G0G1 and G2M phases, Endocrinology 133 (1993), 2881-2888.
32. T. Taguchi, Z. Jian-Yuan, M. Feder, S. Litwin, A.J.P. Klein-Szanto and J.R. Testa, Detection of aneuploidy in interphase nuclei from non-small cell lung carcinomas by fluorescence in situ hybridization using chromosome-specific repetitive DNA probes, Cancer Genet. Cytogenet. 89 (1996), 120-125.
33. E. Vand den Berg, J.W. Oosterhuis, B. De Jong, J. Buist, A.M. Vos, A. Dam and B. Vermeij, Cytogenetics of thyroid adenomas, Cancer Genet. Cytogenet. 44 (1990), 217-222.
34. H. Walt, P. Emmerich, Th. Cremer, M.C. Hofmann and F. Babbwart, Supernumery chromosome 1 in interphase nuclei of atypical germ cells in paraffin-embedded human seminiferous tubules, Lab. Invest. 61 (1989), 527-531.
35. J. Zajicek, Aspiration Biopsy Cytology: Part I. Cytology of Supradiaphragmatic Organs, G.L. Wied, ed., Monograph in Clinical Cytology, Vol. 4, S. Karger, Basel, 1974, p. 73.